http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110076053-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 2009-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2319dffad03d3f3597afcb775fac4d3 |
| publicationDate | 2011-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20110076053-A |
| titleOfInvention | Composition for the prevention and treatment of metabolic diseases containing Spanish oregano extract or summer sageberry extract as an active ingredient |
| abstract | The present invention is Spanish oregano ( Thymus) capitatus ) extract or Sageja ( Satureja) hortensis ) relates to a composition for preventing and treating metabolic diseases selected from the group consisting of obesity, fatty liver and hyperlipidemia as an active ingredient. The present invention is used for the treatment of metabolic diseases of Spanish oregano extract or summer sageberry extract, the composition for the prevention and treatment of metabolic diseases selected from the group consisting of Spanish oregano or summer sagebori extract as an active ingredient, obesity, fatty liver and hyperlipidemia to provide. Since the composition of the present invention has an effect of reducing weight, inhibiting accumulation of visceral fat, relieving fatty liver and significantly lowering cholesterol in plasma and liver tissue, it is effectively used for the prevention and treatment of metabolic diseases selected from the group consisting of obesity, fatty liver and hyperlipidemia. Can be. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-306521-B6 |
| priorityDate | 2009-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.